Before Starting Dialysis, Patients Need Nephrologist Care For patients with end-stage renal disease (ESRD), receiving care from a nephrologist in the months before starting dialysis reduces the risk of death during the first year on dialysis, reports a study in the May 2009 issue of the Journal of the American Society of Nephrology (JASN).
Source: www.medicalnewstoday.comOramed Pharmaceuticals To Present Oral Insulin Phase 2A Trial Results At The Upcoming Annual Meeting Of The ADA (June 5-9, New Orleans, LA) Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.
Source: www.medicalnewstoday.comResults From Efficacy And Safety Study Of Corthera's Relaxin In Acute Heart Failure To Be Presented At Late-Breaking Clinical Trials Session Results from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at 10:30 a.m. EDT on Sunday, March 29, at the American College of Cardiology's (ACC) 58th Annual Scientific Session in Orlando, Fla. John R. Teerlink, M.D.
Source: www.medicalnewstoday.comRadius Initiates Phase 2a Clinical Trial Of RAD1901 In Menopausal Hot Flashes Radius Health ("Radius") announced that the first patient has been dosed in the company's proof-of-concept Phase 2a study of RAD1901, an investigational selective estrogen receptor modulator (SERM) undergoing clinical evaluation for treatment of vasomotor symptoms (menopausal hot flashes). The clinical trial is designed to evaluate the ability of RAD1901 to relieve menopausal hot flashes without the administration of estrogen.
Source: www.medicalnewstoday.comStudy Examines Use Of Massachusetts Community Health Centers, JAMA Commentary Discusses Hospital Safety "How Is The Primary Care Safety Net Faring in Massachusetts? Community Health Centers In The Midst of Health Reform," Kaiser Family Foundation's Commission on Medicaid and the Uninsured: The study conducted by researchers at the George Washington University School of Public Health and Health Servic
Source: www.medicalnewstoday.comImQuest Presentations At Keystone Symposium Focus On Advancements In Their Therapeutic And Microbicide Development Programs ImQuest Life Sciences presented their latest biological results supporting the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the Prevention of meeting being held in Keystone, Colorado.
Source: www.medicalnewstoday.comAutism Study Finds Significant Benefit With Hyperbaric Treatment In a medical world that tells parents of autistic children to "accept" the condition of their child, a new study brings not only hope, but actual help, to these families. Lead physician and researcher, Daniel Rossignol, M.D., treats children with autism.
Source: www.medicalnewstoday.comFructose Metabolism By The Brain Increases Food Intake And Obesity The journal Biochemical and Biophysical Research Communications (http://www.elsevier.com/locate/ybbrc) (BBRC), published by Elsevier, will publish an important review this week online, by M.
Source: www.medicalnewstoday.comRainbow Babies & Children's Hospital Opens Most Technologically Advanced NICU In World Parents may never notice the high-tech developments that surround their tiny premature baby in what doctors are touting as the most technically advanced neonatal intensive care unit (NICU) in the world.
Source: www.medicalnewstoday.comNew York State To Offer Low-Income, Disabled Residents Prescription Drug Discount Cards New York state officials on Monday announced a statewide
prescription drug discount card program for residents with disabilities, people who are too young to qualify for Medicare and those whose incomes are too high to qualify for Medicaid, the Rochester Democrat and Chronicle reports.
Source: www.medicalnewstoday.com
# posted by Network @ 5:17 PM
